C-Suite Snippets: Behind The Scenes At Gates Medical Research Institute
In case you missed it: catch up with snippets from interviews recently published by In Vivo.
You may also be interested in...
In Vivo visits Gates Medical Research Institute CEO Dr. Penny Heaton to review its first pipeline of drugs and vaccines to attack four of the world’s biggest killers: TB, malaria, enteric diseases and other conditions affecting maternal, newborn and child health.
Data presentations at next week’s ASH meeting will be vital for Autolus to restore confidence in pipeline.
Infographic: There are two CAR-T therapies on the market, both of which secured their first approvals in 2017. The pipeline of autologous and allogeneic CAR-T options is busy with several candidates in clinical studies. However, getting approval is only one part of getting these breakthrough therapies to patients.